Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non Operating Income: 2015-2024

Historic Non Operating Income for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to $462,000.

  • Insight Molecular Diagnostics' Non Operating Income rose 320.75% to $223,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $651,000, marking a year-over-year increase of 11.28%. This contributed to the annual value of $462,000 for FY2024, which is 17.26% up from last year.
  • According to the latest figures from FY2024, Insight Molecular Diagnostics' Non Operating Income is $462,000, which was up 17.26% from $394,000 recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' Non Operating Income registered a high of $854,000 during FY2021, and its lowest value of -$1.5 million during FY2020.
  • Over the past 3 years, Insight Molecular Diagnostics' median Non Operating Income value was $394,000 (recorded in 2023), while the average stood at $80,333.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Non Operating Income tumbled by 688.77% in 2020, and later surged by 164.07% in 2023.
  • Over the past 5 years, Insight Molecular Diagnostics' Non Operating Income (Yearly) stood at -$1.5 million in 2020, then skyrocketed by 157.90% to $854,000 in 2021, then plummeted by 172.01% to -$615,000 in 2022, then spiked by 164.07% to $394,000 in 2023, then rose by 17.26% to $462,000 in 2024.